AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20023292 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 850 mg twice daily
Number of subjects: 40
Study 20023292 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 18195565 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir monotherapy
Number of subjects: 136
Study 18195565 — intervention group
Group type: COMPARATOR
Intervention: Lopinavir/ritonavir plus zidovudine and lamivudine (triple-drug therapy)
Number of subjects: 136
Study 16390349 — intervention group
Group type: EXPERIMENTAL
Intervention: MMX-budesonide tablets (9 mg)
Number of subjects: 12
Study 16390349 — intervention group
Group type: COMPARATOR
Intervention: MMX-budesonide tablets with food
Number of subjects: 12
Study 16390349 — intervention group
Group type: COMPARATOR
Intervention: MMX-budesonide tablets without food
Number of subjects: 12
Study 14599823 — intervention group
Group type: EXPERIMENTAL
Intervention: Transverse incision with direct closure
Number of subjects: 30
Study 14599823 — intervention group
Group type: COMPARATOR
Intervention: Longitudinal incision with Z-plasty closure
Number of subjects: 30
Study 10826387 — intervention group
Group type: EXPERIMENTAL
Intervention: Critical pathway for CEA care
Number of subjects: 54
Study 8877080 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 345
Study 8877080 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 345
Study 2061981 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer Prevention Reminders, computer-generated lists of overdue screening tests, and smoking and dietary assessment and counseling, supplemented by cancer education materials
Number of subjects: 40
Study 2061981 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 7113712 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (whisky)
Number of subjects: 6
Study 7113712 — intervention group
Group type: EXPERIMENTAL
Intervention: Cheap red wine
Number of subjects: 6
Study 7113712 — intervention group
Group type: EXPERIMENTAL
Intervention: Good regular wines
Number of subjects: 6
Study 7113712 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetic acid
Number of subjects: 6
Study 30794288 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbiome signature analysis in prostate cancer samples
Number of subjects: 0
Study 30794288 — intervention group
Group type: EXPERIMENTAL
Intervention: Hierarchical clustering analysis of microbiome signatures
Number of subjects: 0
Study 30794288 — intervention group
Group type: EXPERIMENTAL
Intervention: PCR and targeted next-generation sequencing (NGS) validation
Number of subjects: 0
Study 30794288 — intervention group
Group type: EXPERIMENTAL
Intervention: PCR validation of Helicobacter
Number of subjects: 0
Study 30794288 — intervention group
Group type: EXPERIMENTAL
Intervention: Viral and Helicobacter integrations
Number of subjects: 0
Study 28216389 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal counselling (VC)
Number of subjects: 105
Study 28216389 — intervention group
Group type: EXPERIMENTAL
Intervention: Trainhaler (TH)
Number of subjects: 105
Study 28216389 — intervention group
Group type: COMPARATOR
Intervention: Verbal counselling (VC) and Trainhaler (TH)
Number of subjects: 105
Study 25899101 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Intermittent Exercise Training (HIIT)
Number of subjects: 30
Study 25899101 — intervention group
Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Exercise Training (MICT)
Number of subjects: 30
Study 25899101 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CON)
Number of subjects: 30
Study 23846995 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 0
Study 22728908 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan
Number of subjects: 60
Study 22728908 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 60
Study 22728908 — intervention group
Group type: COMPARATOR
Intervention: Diet therapy (Control)
Number of subjects: 60
Study 19474114 — intervention group
Group type: EXPERIMENTAL
Intervention: Capecitabine combinations
Number of subjects: 1318
Study 19474114 — intervention group
Group type: COMPARATOR
Intervention: 5-FU combinations
Number of subjects: 1318
Study 18030331 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin detemir (D)
Number of subjects: 34
Study 18030331 — intervention group
Group type: COMPARATOR
Intervention: Human insulin (HI)
Number of subjects: 34
Study 15020037 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride for 7 years
Number of subjects: 18882
Study 15020037 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 7 years
Number of subjects: 18882
Study 11824302 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (locoregional thrombolysis and mechanical thrombectomy)
Number of subjects: 0
Study 9488097 — intervention group
Group type: EXPERIMENTAL
Intervention: Lu 25-109 at 150 mg tid for 7 days (fixed-dose MTD)
Number of subjects: 38
Study 9488097 — intervention group
Group type: EXPERIMENTAL
Intervention: Lu 25-109 at titrated doses (75 mg tid, 100%, 125%, and 150% of fixed dose MTD)
Number of subjects: 38
Study 9488097 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 8072071 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 mg methylprednisolone plus 40 mg nifedipine daily (group 1)
Number of subjects: 86
Study 8072071 — intervention group
Group type: COMPARATOR
Intervention: 16 mg methylprednisolone plus placebo daily (group 2)
Number of subjects: 86
Study 8072071 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine and methylprednisolone (group 1)
Number of subjects: 86
Study 8072071 — intervention group
Group type: COMPARATOR
Intervention: Placebo (group 2)
Number of subjects: 86
Study 3289932 — intervention group
Group type: EXPERIMENTAL
Intervention: Disopyramide
Number of subjects: 90
Study 3289932 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 3289932 — intervention group
Group type: EXPERIMENTAL
Intervention: Disopyramide (after conversion from placebo)
Number of subjects: 90
Study 31474435 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV risk reduction intervention targeting sexual risk behaviors
Number of subjects: 525
Study 31474435 — intervention group
Group type: COMPARATOR
Intervention: Attention-matched control targeting other health behaviors
Number of subjects: 525
Study 29195963 — intervention group
Group type: EXPERIMENTAL
Intervention: Sudoku design with 8 Sudoku 16×16 squares (4 randomized independently and 4 in reverse order)
Number of subjects: 112
Study 29195963 — intervention group
Group type: EXPERIMENTAL
Intervention: Smaller testing sessions using Sudoku design
Number of subjects: 112
Study 25096918 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed irrigation enhanced evacuation (PIEE)
Number of subjects: 24
Study 25096918 — intervention group
Group type: COMPARATOR
Intervention: Polyethylene glycol-electrolyte lavage solution (PEG; CoLyte)
Number of subjects: 24
Study 23457903 — intervention group
Group type: EXPERIMENTAL
Intervention: Symbiot stent
Number of subjects: 90
Study 23457903 — intervention group
Group type: EXPERIMENTAL
Intervention: BMS with FilterWire
Number of subjects: 90
Study 23457903 — intervention group
Group type: COMPARATOR
Intervention: BMS without EPD (control group)
Number of subjects: 90
Study 23457903 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 90
Study 21957706 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-control (SC) group decided when to stop practice
Number of subjects: 0
Study 21957706 — intervention group
Group type: COMPARATOR
Intervention: Yoked group completed the same number of trials as their SC counterparts
Number of subjects: 0
Study 19144444 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine plus platinum
Number of subjects: 2186
Study 19144444 — intervention group
Group type: COMPARATOR
Intervention: Vinorelbine plus platinum
Number of subjects: 2186
Study 17131847 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril treatment
Number of subjects: 78
Study 15126811 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg trospium twice daily
Number of subjects: 523
Study 15126811 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 523
Study 11204096 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructional biasing
Number of subjects: 0
Study 11204096 — intervention group
Group type: COMPARATOR
Intervention: Silent control conditions
Number of subjects: 0
Study 9801884 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone-iodine 4% solution
Number of subjects: 50
Study 9801884 — intervention group
Group type: COMPARATOR
Intervention: Saline irrigation
Number of subjects: 50
Study 7831637 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled lignocaine (20 mg)
Number of subjects: 10
Study 7831637 — intervention group
Group type: COMPARATOR
Intervention: Adrenaline (400 micrograms)
Number of subjects: 10
Study 3139811 — intervention group
Group type: EXPERIMENTAL
Intervention: 3o PDS (Polydioxanone) to fascia plus 3o Prolene to skin
Number of subjects: 40
Study 3139811 — intervention group
Group type: COMPARATOR
Intervention: 2o chromic catgut to fascia plus 3o silk to skin
Number of subjects: 40
Study 28899262 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrieval practice with discrepancy detection
Number of subjects: 0
Study 28899262 — intervention group
Group type: COMPARATOR
Intervention: Control group with discrepancy detection
Number of subjects: 0
Study 28899262 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent assessment of misinformation narratives
Number of subjects: 0
Study 28209296 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous mitomycin (12 mg/m2 on day 1) or intravenous cisplatin (60 mg/m2 on days 1 and 29), with intravenous fluorouracil (1000 mg/m2 per day on days 1-4 and 29-32) and radiotherapy (50.4 Gy in 28 daily fractions)
Number of subjects: 940
Study 28209296 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance chemotherapy (fluorouracil and cisplatin)
Number of subjects: 940
Study 28209296 — intervention group
Group type: COMPARATOR
Intervention: No maintenance chemotherapy
Number of subjects: 940
Study 28209296 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 940
Study 28209296 — intervention group
Group type: EXPERIMENTAL
Intervention: Progression-free survival
Number of subjects: 940
Study 26439877 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplementation (200 μg Se as Se yeast) daily for 6 months
Number of subjects: 58
Study 26439877 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplementation
Number of subjects: 58
Study 24268128 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive intervention consisting of six sessions of 90 minutes each.
Number of subjects: 160
Study 24268128 — intervention group
Group type: COMPARATOR
Intervention: Control group (details not specified).
Number of subjects: 160
Study 21956384 — intervention group
Group type: EXPERIMENTAL
Intervention: Small-central lesions
Number of subjects: 45
Study 21956384 — intervention group
Group type: EXPERIMENTAL
Intervention: Large-central lesions
Number of subjects: 45
Study 21956384 — intervention group
Group type: EXPERIMENTAL
Intervention: DBRFS (Disfigured/Bothersome/Repair Factor Score) for small-central to large-central lesions
Number of subjects: 45
Study 21956384 — intervention group
Group type: EXPERIMENTAL
Intervention: DBRFS for small-central to large-peripheral lesions
Number of subjects: 45
Study 21956384 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall attractiveness penalty
Number of subjects: 45
Study 21956384 — intervention group
Group type: EXPERIMENTAL
Intervention: Importance to repair
Number of subjects: 45
Study 21956384 — intervention group
Group type: EXPERIMENTAL
Intervention: All large lesions and small central lesions
Number of subjects: 45
Study 18280967 — intervention group
Group type: EXPERIMENTAL
Intervention: Melaleuca alternifolia mixed with Coe‐Comfort
Number of subjects: 27
Study 18280967 — intervention group
Group type: EXPERIMENTAL
Intervention: Nystatin mixed with Coe‐Comfort
Number of subjects: 27
Study 18280967 — intervention group
Group type: COMPARATOR
Intervention: Coe‐Comfort (Control Group)
Number of subjects: 27
Study 17194267 — intervention group
Group type: EXPERIMENTAL
Intervention: Zonisamide (100-600 mg/day)
Number of subjects: 60
Study 17194267 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 12749487 — intervention group
Group type: EXPERIMENTAL
Intervention: Permethrin-treated bed nets (ITNs)
Number of subjects: 296
Study 12749487 — intervention group
Group type: COMPARATOR
Intervention: Control villages
Number of subjects: 296
Study 12489598 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced external counterpulsation (EECP)
Number of subjects: 0
Study 9530459 — intervention group
Group type: EXPERIMENTAL
Intervention: Total intravenous anaesthesia with propofol and remifentanil
Number of subjects: 50
Study 9530459 — intervention group
Group type: COMPARATOR
Intervention: Inhalational anaesthesia with desflurane and nitrous oxide
Number of subjects: 50
Study 8030454 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 micrograms ethinyl estradiol with 75 micrograms gestodene
Number of subjects: 53
Study 8030454 — intervention group
Group type: COMPARATOR
Intervention: 20 micrograms ethinyl estradiol with 150 micrograms desogestrel
Number of subjects: 53
Study 2690620 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin
Number of subjects: 91
Study 2690620 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin
Number of subjects: 91
Study 2690620 — intervention group
Group type: COMPARATOR
Intervention: Erythromycin
Number of subjects: 91
Study 932317 — intervention group
Group type: EXPERIMENTAL
Intervention: Schizophrenic subjects
Number of subjects: 35
Study 932317 — intervention group
Group type: COMPARATOR
Intervention: Normal subjects
Number of subjects: 35
Study 30293107 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week mixed power training (MPT), three times/week, 75 min/session
Number of subjects: 2
Study 28070784 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent scaffolding and child emotion regulation (ER)
Number of subjects: 51
Study 28070784 — intervention group
Group type: COMPARATOR
Intervention: Parent co-regulation strategies
Number of subjects: 51
Study 25472625 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-affirmation intervention
Number of subjects: 0
Study 23439658 — intervention group
Group type: EXPERIMENTAL
Intervention: High load resistance exercise (6-8 repetition maximum)
Number of subjects: 17
Study 23439658 — intervention group
Group type: EXPERIMENTAL
Intervention: Low load resistance exercise (15-20 repetition maximum)
Number of subjects: 17
Study 23439658 — intervention group
Group type: COMPARATOR
Intervention: Comparison between high load and low load resistance exercise
Number of subjects: 17
Study 21680536 — intervention group
Group type: EXPERIMENTAL
Intervention: Female patients with multiple myeloma
Number of subjects: 1960
Study 21680536 — intervention group
Group type: COMPARATOR
Intervention: Male patients with multiple myeloma
Number of subjects: 1960
Study 18058651 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone position
Number of subjects: 120
Study 18058651 — intervention group
Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 120
Study 16019040 — intervention group
Group type: EXPERIMENTAL
Intervention: Word stem completion task with novel items
Number of subjects: 22
Study 16019040 — intervention group
Group type: EXPERIMENTAL
Intervention: Word stem completion task with repeated items
Number of subjects: 22
Study 16019040 — intervention group
Group type: COMPARATOR
Intervention: Control group (age-matched controls)
Number of subjects: 22
Study 12848597 — intervention group
Group type: EXPERIMENTAL
Intervention: lercanidipine 10 mg once daily
Number of subjects: 110
Study 10706056 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine (CSA)
Number of subjects: 14
Study 10706056 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 14
Study 10706056 — intervention group
Group type: COMPARATOR
Intervention: Rapamycin (Control)
Number of subjects: 14
Study 9483355 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (reviparin sodium, Clivarin) s.c. once daily with graduated elastic stockings (n = 359)
Number of subjects: 718
Study 9483355 — intervention group
Group type: COMPARATOR
Intervention: Graduated elastic stockings only (n = 359)
Number of subjects: 718
Study 8460391 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium infusion (10 mg/kg body weight) administered 12 hours and 1 hour prior to operation
Number of subjects: 80
Study 8460391 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 29911893 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Prevention Programme (IPP)
Number of subjects: 310
Study 29911893 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 310
Study 29247148 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixekizumab 80 mg every 2 weeks (IXEQ2W)
Number of subjects: 381
Study 29247148 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixekizumab 80 mg every 4 weeks (IXEQ4W)
Number of subjects: 381
Study 29247148 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixekizumab (IXE)
Number of subjects: 381
Study 29247148 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 381
Study 29247148 — intervention group
Group type: COMPARATOR
Intervention: Adalimumab (ADA) 40 mg Q2W
Number of subjects: 381
Study 27160199 — intervention group
Group type: EXPERIMENTAL
Intervention: Salt restriction (6 weeks)
Number of subjects: 46
Study 25248812 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous PFO closure
Number of subjects: 0
Study 25248812 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 0
Study 22769235 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous alendronate (ALN) 900 µg every 4 weeks
Number of subjects: 325
Study 22769235 — intervention group
Group type: COMPARATOR
Intervention: Oral alendronate (ALN) 35 mg once weekly
Number of subjects: 325
Study 20410849 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity interventions (various types, including supervised exercise, moderate- or high-intensity PA)
Number of subjects: 3289
Study 20410849 — intervention group
Group type: COMPARATOR
Intervention: Control conditions (not specified)
Number of subjects: 3289
Study 17931376 — intervention group
Group type: EXPERIMENTAL
Intervention: 90-minute group educational programme on breastfeeding
Number of subjects: 46
Study 17931376 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 46
Study 15923147 — intervention group
Group type: EXPERIMENTAL
Intervention: PBL group (n=104)
Number of subjects: 207
Study 15923147 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=103)
Number of subjects: 207
Study 12392381 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptomatic group exposed to ragweed pollen until predetermined severities of AR symptoms were demonstrated.
Number of subjects: 0
Study 12392381 — intervention group
Group type: COMPARATOR
Intervention: Asymptomatic group not exposed to ragweed pollen, retaining a minimum symptom profile.
Number of subjects: 0
Study 10359738 — intervention group
Group type: EXPERIMENTAL
Intervention: DDD pacing
Number of subjects: 48
Study 10359738 — intervention group
Group type: COMPARATOR
Intervention: Pacing backup (AAI‐30)
Number of subjects: 48
Study 8569943 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetate dialysis
Number of subjects: 10
Study 1936331 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate
Number of subjects: 79
Study 1936331 — intervention group
Group type: EXPERIMENTAL
Intervention: Centrifugation/swim‐up
Number of subjects: 79
Study 1936331 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct IP insemination or controlled ovarian hyperstimulation
Number of subjects: 79
Study 7125768 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education program
Number of subjects: 0
Study 30809536 — intervention group
Group type: EXPERIMENTAL
Intervention: Training group (TG) - 15-week combined exercise programme (strength, aerobic fitness, stability, flexibility)
Number of subjects: 45
Study 30809536 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) - No intervention
Number of subjects: 45
Study 29072015 — intervention group
Group type: EXPERIMENTAL
Intervention: LI 18‐EA
Number of subjects: 216
Study 29072015 — intervention group
Group type: EXPERIMENTAL
Intervention: LI 4‐PC 6‐EA
Number of subjects: 216
Study 29072015 — intervention group
Group type: EXPERIMENTAL
Intervention: LI 4‐PC 6‐TAES
Number of subjects: 216
Study 29072015 — intervention group
Group type: COMPARATOR
Intervention: GB 34‐EA
Number of subjects: 216
Study 29072015 — intervention group
Group type: COMPARATOR
Intervention: non‐acupoint‐EA
Number of subjects: 216
Study 26013711 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous (SQ) insulin glargine in combination with intravenous (IV) insulin
Number of subjects: 40
Study 26013711 — intervention group
Group type: COMPARATOR
Intervention: Intravenous (IV) insulin (standard care control)
Number of subjects: 40
Study 23353610 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate loading with 18% carbohydrate beverage (375 mL between 9 pm and 12 pm, and 250 mL at 6:30 am)
Number of subjects: 6
Study 23353610 — intervention group
Group type: COMPARATOR
Intervention: Control group (drank only water)
Number of subjects: 6
Study 21207018 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide-SR 40 mg
Number of subjects: 66
Study 21207018 — intervention group
Group type: COMPARATOR
Intervention: Control (methylprednisolone plus celecoxib without isosorbide-SR)
Number of subjects: 66
Study 19273960 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin glue plus 20 million ASCs
Number of subjects: 49
Study 19273960 — intervention group
Group type: COMPARATOR
Intervention: Fibrin glue alone
Number of subjects: 49
Study 19273960 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin glue plus 40 million ASCs (if healing not seen at eight weeks)
Number of subjects: 49
Study 19273960 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life scores
Number of subjects: 49
Study 19273960 — intervention group
Group type: EXPERIMENTAL
Intervention: ASCs treatment
Number of subjects: 49
Study 17496227 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung volume reduction surgery (LVRS)
Number of subjects: 110
Study 17496227 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 110